| ASSET | QUARTER | % RETURN |
|---|---|---|
Freedom (FRHC) | Q2 1995 | 3,013,859.39% |
Argan (AGX) | Q4 1995 | 7,001.14% |
Gyrodyne Company of America (GYRO) | Q3 1995 | 910.07% |
Idaho Strategic Resources (IDR) | Q3 1995 | 525% |
SunOpta (STKL) | Q1 1995 | 450% |
American Shared Hospital Service (AMS) | Q2 1995 | 420.08% |
AutoNation (AN) | Q2 1995 | 375.81% |
Semtech (SMTC) | Q1 1995 | 338% |
NVE (NVEC) | Q2 1995 | 300% |
Gulf Resources (GURE) | Q3 1995 | 277.42% |
Wolfspeed (WOLF) | Q2 1995 | 270.58% |
Onto Innovation (ONTO) | Q2 1995 | 225% |
Abeona Therapeutics (ABEO) | Q4 1995 | 209.09% |
Hudson Technologies (HDSN) | Q1 1995 | 200% |
Champions Oncology (CSBR) | Q3 1995 | 175% |
Onto Innovation (ONTO) | Q1 1995 | 170% |
SunOpta (STKL) | Q2 1995 | 163.64% |
Lifevantage (LFVN) | Q4 1995 | 150% |
Cyanotech (CYAN) | Q2 1995 | 150% |
Sanara Medtech (SMTI) | Q4 1995 | 150% |
Biogen (BIIB) | Q4 1995 | 147.62% |
Kulicke and Soffa Industries (KLIC) | Q2 1995 | 142.24% |
Cyanotech (CYAN) | Q4 1995 | 134.15% |
CryoCell International (CCEL) | Q1 1995 | 131.25% |
Lineage Cell Therapeutics (LCTX) | Q3 1995 | 125.03% |
